News

The primary study endpoints were reduction of Post Prandial Blood Sugar (PPBS) by 20mg/dl from the baseline value and reduction of glycosylated hemoglobin (HbA1c) by 0.7% from the

The ADO II is a self-expanding nitinol mesh device and is designed to be introduced in a minimally invasive fashion through a catheter. The ADO II expands the

The registry will enroll up to 2,500 patients with simple and complex lesions at multiple sites in several European countries. Of the patients at each site, half will

All of the infection control company’s safety and standard syringe products are available to Yankee Alliance members including the InviroSNAP with InviroSTRIPE, featuring a patented, integral write-on stripe

Oritavancin would be indicated for the treatment of complicated skin and skin structure infections (cSSSI) caused by gram-positive bacteria, including methicillin-resistant Staphylococcus aureus (MRSA). The oritavancin NDA submission

The patient was treated with the Cook Zenith Dissection Endovascular System, which is comprised of the new Cook Zenith Dissection Stent, used in conjunction with the Cook Zenith

Sentry will warehouse and distribute more than 500,000 vaccine doses from its pharmaceutical cold chain logistics center. Ensuring product integrity, supply chain security and fast, efficient distribution is

Under terms of the agreement, Schering-Plough will reimburse OraSure for certain development costs and will provide payments to OraSure based on the achievement of certain regulatory and commercial

The series B financing was co-led by Advanced Technology Ventures and IDG Ventures Boston and included participation from series A investor, MedVenture Associates and new investor Harris &